Numinus Wellness Inc. (NUMIF)

Market Cap	7.48M +13.8%
Revenue (ttm)	4.71M +11.1%
Net Income	-10.62M
EPS	-0.03
Shares Out	320.55M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0220
Previous Close	0.0210
Day's Range	0.0220 - 0.0220
52-Week Range	0.0055 - 0.0560
Beta	2.62
Analysts	Hold
Price Target	0.25 (0.0%)
Earnings Date	Jun 12, 2026

About Numinus Wellness

Numinus Wellness Inc. provides psychedelic-assisted therapy training, lab testing, and psychotherapy services in Canada and the United States. The company operates through Clinical Research Operations and Practitioner Training segments. It also provides clinical research management services to academic institutions and biotechnology companies. In addition, the company engages in the provision of education and training for research and drug development organizations to support clinical trials and commercialization efforts. Numinus Wellness Inc. ...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1964
• Employees: 16
• Stock Exchange: OTCMKTS
• Ticker Symbol: NUMIF

Financial Performance

In fiscal year 2024, Numinus Wellness's revenue was 4.17 million, an increase of 11.08% compared to the previous year's 3.75 million. Losses were -19.64 million, -35.08% less than in 2023.

Financial numbers in CAD